K279-1522 Screening compound: 2-[5-({2-[(3,4-DIMETHOXYPHENETHYL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]-N~1~-PHENETHYLACETAMIDE

K279-1522 Screening compound: 2-[5-({2-[(3,4-DIMETHOXYPHENETHYL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]-N~1~-PHENETHYLACETAMIDE
K279-1522 Screening compound: 2-[5-({2-[(3,4-DIMETHOXYPHENETHYL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]-N~1~-PHENETHYLACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1522
2-[5-({2-[(3,4-DIMETHOXYPHENETHYL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]-N~1~-PHENETHYLACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1522

Molecular Formula

C32H33N5O5S (C32 H33 N5 O5 S)

Compound Name

2-[5-({2-[(3,4-DIMETHOXYPHENETHYL)AMINO]-2-OXOETHYL}SULFANYL)-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL]-N~1~-PHENETHYLACETAMIDE

IUPAC name

n/a

SMILES

COc(ccc(CCNC(CSC(N1C2CC(NCCc3ccccc3)=O)=Nc(cccc3)c3C1=NC2=O)=O)c1)c1OC

InChI

InChI=1S/C32H33N5O5S/c1-41-26-13-12-22(18-27(26)42-2)15-17-34-29(39)20-43-32-35-24-11-7-6-10-23(24)30-36-31(40)25(37(30)32)19-28(38)33-16-14-21-8-4-3-5-9-21/h3-13,18,25H,14-17,19-20H2,1-2H3,(H,33,38)(H,34,39)/t25-/m0/s1

InChI Key

VBJMQKCALFRDEY-VWLOTQADSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

599.71

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.479

Distribution Coefficient, logD

1.478

Water Solubility, LogSw

-2.51

Polar Surface Area

99.038

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.10

K279-1522 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K279-1522 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1522?
Check Price and Availability of K279-1522, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1522 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1522
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1522
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1522 available by request